UniProt ID | WASL_HUMAN | |
---|---|---|
UniProt AC | O00401 | |
Protein Name | Neural Wiskott-Aldrich syndrome protein | |
Gene Name | WASL | |
Organism | Homo sapiens (Human). | |
Sequence Length | 505 | |
Subcellular Localization | Nucleus . Cytoplasm . Cytoplasm, cytoskeleton . Preferentially localized in the cytoplasm when phosphorylated and in the nucleus when unphosphorylated. Exported from the nucleus by an nuclear export signal (NES)-dependent mechanism to the cytoplasm. | |
Protein Description | Regulates actin polymerization by stimulating the actin-nucleating activity of the Arp2/3 complex. Involved in mitosis and cytokinesis, via its role in the regulation of actin polymerization. Binds to HSF1/HSTF1 and forms a complex on heat shock promoter elements (HSE) that negatively regulates HSP90 expression. Plays a role in dendrite spine morphogenesis (By similarity).. | |
Protein Sequence | MSSVQQQPPPPRRVTNVGSLLLTPQENESLFTFLGKKCVTMSSAVVQLYAADRNCMWSKKCSGVACLVKDNPQRSYFLRIFDIKDGKLLWEQELYNNFVYNSPRGYFHTFAGDTCQVALNFANEEEAKKFRKAVTDLLGRRQRKSEKRRDPPNGPNLPMATVDIKNPEITTNRFYGPQVNNISHTKEKKKGKAKKKRLTKADIGTPSNFQHIGHVGWDPNTGFDLNNLDPELKNLFDMCGISEAQLKDRETSKVIYDFIEKTGGVEAVKNELRRQAPPPPPPSRGGPPPPPPPPHNSGPPPPPARGRGAPPPPPSRAPTAAPPPPPPSRPSVAVPPPPPNRMYPPPPPALPSSAPSGPPPPPPSVLGVGPVAPPPPPPPPPPPGPPPPPGLPSDGDHQVPTTAGNKAALLDQIREGAQLKKVEQNSRPVSCSGRDALLDQIRQGIQLKSVADGQESTPPTPAPTSGIVGALMEVMQKRSKAIHSSDEDEDEDDEEDFEDDDEWED | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSSVQQQPP ------CCCCCCCCC | 38.94 | 19413330 | |
15 | Phosphorylation | PPPPRRVTNVGSLLL CCCCCCCCCCCCEEE | 23.52 | 27273156 | |
19 | Phosphorylation | RRVTNVGSLLLTPQE CCCCCCCCEEECCCC | 16.15 | 27251275 | |
23 | Phosphorylation | NVGSLLLTPQENESL CCCCEEECCCCCCCH | 23.93 | - | |
58 | Phosphorylation | ADRNCMWSKKCSGVA HCCCCCCCCCCCCEE | 8.71 | - | |
62 | Phosphorylation | CMWSKKCSGVACLVK CCCCCCCCCEEEEEC | 45.22 | 29759185 | |
95 | Phosphorylation | LLWEQELYNNFVYNS EEEEEEHHHCCCCCC | 13.80 | - | |
100 | Phosphorylation | ELYNNFVYNSPRGYF EHHHCCCCCCCCCEE | 13.04 | 27642862 | |
102 | Phosphorylation | YNNFVYNSPRGYFHT HHCCCCCCCCCEEEC | 9.78 | 24719451 | |
132 | Malonylation | EEAKKFRKAVTDLLG HHHHHHHHHHHHHHH | 50.79 | 26320211 | |
135 | Phosphorylation | KKFRKAVTDLLGRRQ HHHHHHHHHHHHHHH | 26.28 | - | |
170 | Phosphorylation | DIKNPEITTNRFYGP ECCCCCCCCCCCCCC | 19.16 | 21945579 | |
171 | Phosphorylation | IKNPEITTNRFYGPQ CCCCCCCCCCCCCCC | 30.02 | 21945579 | |
175 | Phosphorylation | EITTNRFYGPQVNNI CCCCCCCCCCCCCCC | 25.34 | 21945579 | |
183 | Phosphorylation | GPQVNNISHTKEKKK CCCCCCCCCCCHHHC | 27.51 | 28985074 | |
185 | Phosphorylation | QVNNISHTKEKKKGK CCCCCCCCCHHHCCC | 33.82 | 25159151 | |
186 | Ubiquitination | VNNISHTKEKKKGKA CCCCCCCCHHHCCCC | 63.21 | 32015554 | |
205 | Phosphorylation | LTKADIGTPSNFQHI CCCCCCCCCCCCCCC | 24.71 | 25159151 | |
207 | Phosphorylation | KADIGTPSNFQHIGH CCCCCCCCCCCCCEE | 50.55 | 25627689 | |
242 | Phosphorylation | LFDMCGISEAQLKDR HHHHHCCCHHHHCCC | 16.50 | 16257963 | |
251 | Phosphorylation | AQLKDRETSKVIYDF HHHCCCCHHHHHHHH | 34.44 | 28152594 | |
252 | Phosphorylation | QLKDRETSKVIYDFI HHCCCCHHHHHHHHH | 21.85 | 28152594 | |
253 | Ubiquitination | LKDRETSKVIYDFIE HCCCCHHHHHHHHHH | 39.82 | 29967540 | |
256 | Phosphorylation | RETSKVIYDFIEKTG CCHHHHHHHHHHHHC | 14.05 | 19664994 | |
261 | Ubiquitination | VIYDFIEKTGGVEAV HHHHHHHHHCCHHHH | 47.88 | 29967540 | |
274 | Methylation | AVKNELRRQAPPPPP HHHHHHHHCCCCCCC | 50.03 | 115484371 | |
284 | Methylation | PPPPPPSRGGPPPPP CCCCCCCCCCCCCCC | 60.92 | 115367429 | |
305 | Methylation | GPPPPPARGRGAPPP CCCCCCCCCCCCCCC | 40.91 | 115484361 | |
307 | Methylation | PPPPARGRGAPPPPP CCCCCCCCCCCCCCC | 32.33 | 24129315 | |
329 | Methylation | PPPPPPSRPSVAVPP CCCCCCCCCCCCCCC | 33.03 | 115484351 | |
426 | Phosphorylation | LKKVEQNSRPVSCSG HHCHHHCCCCCCCCC | 37.34 | 29255136 | |
430 | Phosphorylation | EQNSRPVSCSGRDAL HHCCCCCCCCCHHHH | 12.78 | 30266825 | |
432 | Phosphorylation | NSRPVSCSGRDALLD CCCCCCCCCHHHHHH | 29.38 | 30266825 | |
449 | Phosphorylation | RQGIQLKSVADGQES HHCCCCEECCCCCCC | 31.00 | 22199227 | |
456 | Phosphorylation | SVADGQESTPPTPAP ECCCCCCCCCCCCCC | 38.02 | 22199227 | |
457 | Phosphorylation | VADGQESTPPTPAPT CCCCCCCCCCCCCCC | 32.32 | 22199227 | |
460 | Phosphorylation | GQESTPPTPAPTSGI CCCCCCCCCCCCCHH | 33.03 | 22199227 | |
464 | Phosphorylation | TPPTPAPTSGIVGAL CCCCCCCCCHHHHHH | 41.51 | 22199227 | |
465 | Phosphorylation | PPTPAPTSGIVGALM CCCCCCCCHHHHHHH | 26.01 | 22199227 | |
479 | Phosphorylation | MEVMQKRSKAIHSSD HHHHHHHHHHHCCCC | 33.21 | 25072903 | |
484 | Phosphorylation | KRSKAIHSSDEDEDE HHHHHHCCCCCCCCC | 33.11 | 28176443 | |
485 | Phosphorylation | RSKAIHSSDEDEDED HHHHHCCCCCCCCCC | 30.75 | 28176443 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
242 | S | Phosphorylation | Kinase | TNK2 | Q07912 | Uniprot |
256 | Y | Phosphorylation | Kinase | ABL2 | Q4JIM5 | GPS |
256 | Y | Phosphorylation | Kinase | TNK2 | Q07912 | Uniprot |
256 | Y | Phosphorylation | Kinase | PTK2 | Q05397 | GPS |
484 | S | Phosphorylation | Kinase | PAK4 | O96013 | PSP |
485 | S | Phosphorylation | Kinase | PAK4 | O96013 | PSP |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of WASL_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-484 AND SER-485, ANDMASS SPECTROMETRY. | |
"Phosphorylation of WASP by the Cdc42-associated kinase ACK1: dualhydroxyamino acid specificity in a tyrosine kinase."; Yokoyama N., Lougheed J., Miller W.T.; J. Biol. Chem. 280:42219-42226(2005). Cited for: PHOSPHORYLATION AT SER-242 AND TYR-256 BY TNK2, AND INTERACTION WITHWASL. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-256, AND MASSSPECTROMETRY. | |
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-256, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-256, AND MASSSPECTROMETRY. |